Nectar Lifesciences Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nectar Lifesciences Limited generated cash of $2,246,860,000, which is more than the previous year. Cash used in financing activities reached the amount of -$2,054,350,000 last year. Net change in cash is therefore $22,260,000.
Cash Flow
| 2010 | -877.18M | -1.45B | 2.33B |
|---|---|---|---|
| 2011 | 421.37M | -1.66B | 1.22B |
| 2012 | 1.64B | -2.33B | 619.47M |
| 2016 | 1.63B | -726.87M | -874.16M |
| 2018 | 651.67M | -294.35M | -396.02M |
| 2020 | 2.84B | -331.28M | -2.51B |
| 2021 | 213.79M | -286.24M | 114.9M |
| 2023 | 1.33B | 517.03M | -1.85B |
| 2024 | 2.24B | -170.25M | -2.05B |
NECLIFE.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 175.8M | 178.07M | 212.94M | 213.27M | 131.81M | 333.82M | 325.75M | 347.9M | 344.74M |
Operating activities | |||||||||
Net income | 49.95M | -424.19M | -594.53M | 374.71M | 626.83M | 724.9M | 732.16M | 1.03B | 922.89M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 607.18M | 591.18M | 602.53M | 607.66M | 643.09M | 781.11M | 607.22M | 460.96M | 387.46M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 328.42M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 2.24B | 1.33B | 213.79M | 2.84B | 651.67M | 1.63B | 1.64B | 421.37M | -877.18M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -800.38M | -2.5M | -189.40M | -1M | -2.08M | 0 | 0 | -201.26M |
Investments In Property Plant And Equipment | -294.15M | -300.60M | -312.41M | -547.7M | -331.63M | -780.35M | -2.58B | -1.98B | -1.41B |
Acquisitions Net | 0 | 797.88M | 1.85M | 185.27M | 4.09M | 740K | 0 | 0 | 0 |
Cash generated by investing activities | -170.25M | 517.03M | -286.24M | -331.28M | -294.35M | -726.87M | -2.33B | -1.66B | -1.45B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.52B |
Payments for dividends | 0 | 0 | -11.21M | -13.54M | -13.5M | -22.47M | -22.43M | 0 | -53.29M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.18B | -1.06B | -1.24B | -1.24B | 769.49M | 53.88M | -2.27B | 0 | 0 |
Cash used in financing activities | -2.05B | -1.85B | 114.9M | -2.51B | -396.02M | -874.16M | 619.47M | 1.22B | 2.33B |
Net Change In Cash | 22.26M | -2.27M | 42.45M | -340K | -38.7M | 32.65M | -66.5M | -22.15M | 3.16M |
Cash at end of period | 198.06M | 175.8M | 255.39M | 212.93M | 93.11M | 366.47M | 259.25M | 325.75M | 347.9M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |